亨廷丁编码的多质胺扩张在体外和体内生物中形成粉样蛋白质聚合物

相关实验视频

Updated: May 5, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

E Scherzinger¹, R Lurz, M Turmaine

¹Max-Planck-Institut für Molekulare Genetik, Berlin, Germany.

|August 8, 1997

概括

在亨廷顿病 (HD) 中,致病性多重胺扩张形成不溶性蛋白质聚合物. 这些在体外和转基因小鼠模型中观察到的结构与其他神经退行性疾病中发现的结构相似.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
蛋白质生物化学蛋白质生物化学

背景情况:

亨廷顿病 (HD) 是一种神经退行性疾病,其特征在于亨廷丁蛋白中多重胺 (PolyQ) 重复的异常扩张.
驱动PolyQ诱导的神经退行的精确分子机制仍然不完全理解.
蛋白质聚合是许多神经退行性疾病的标志,包括HD,阿尔茨海默病和子疾病.

研究的目的:

研究由GST-huntingtin融合蛋白与扩展的PolyQ序列的蛋白质分解裂变产生的蛋白质聚合物的形成和形态.
为研究亨廷顿病的分子病理学建立一个体外模型.

主要方法:

具有不同长度的PolyQ的GST-huntingtin融合蛋白的蛋白质分解裂变.
生物化学分析检测不溶性高分子量蛋白质聚合物.
电子显微镜可视化聚合物形态.
在HD的转基因小鼠模型中进行亚细胞分离和超结构分析.

主要成果:

GST-huntingtin融合蛋白的蛋白质分解裂变仅在PolyQ扩张在致病范围内时引起不溶性聚合物形成.
电子显微镜揭示了这些聚合物的纤维状或带状形态,类似于疹子和β-粉样纤维.
在转基因的HD小鼠体内研究证实了脑组织中类似结构的存在.

结论:

致病性多重胺扩张对于不溶性,高分子量蛋白质聚合物的形成至关重要.
观察到的总体形态表明,在不同神经退行性疾病中蛋白质聚合中存在共同的结构动机.
开发的体外模型为了解HD分子病理学和开发治疗策略提供了有价值的工具.

更多相关视频

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Huntington Disease l: Introduction

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...